Volatile Week, but Green? Click to watch the new Podcast.

$3.07 (-4.66%)

Volume: 20.208k

Closed: Jul 05, 2022

Hollow Logo Score: 1.589

Evoke Pharma Stock Forecast

BUY SELL NASDAQ:EVOK
$3.07 (-4.66%)

Volume: 20.208k

Closed: Jul 05, 2022

Score Hollow Logo 1.589

EVOK Price Targets and Analyst Ratings NASDAQ:EVOK

Historical Ratings and Targets

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2020-06-22 225.73% HC Wainwright & Co. $10.00 Upgrades Neutral Buy

EVOK Stock Trend

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 967.87% during the next 3 months and, with a 90% probability hold a price between $21.36 and $42.52 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-07-07 $2.06 $3.05 $4.04
2022-07-08 $2.12 $3.11 $4.10
2022-07-11 $2.18 $3.17 $4.16
2022-07-12 $2.24 $3.23 $4.22
2022-07-13 $2.30 $3.29 $4.28
2022-07-14 $2.36 $3.35 $4.34
2022-07-15 $2.42 $3.41 $4.40
2022-07-18 $2.48 $3.47 $4.46
2022-07-19 $2.54 $3.53 $4.52
2022-07-20 $2.60 $3.59 $4.58
2022-07-21 $2.66 $3.65 $4.64
2022-07-22 $2.72 $3.71 $4.70
2022-07-25 $2.78 $3.77 $4.76
2022-07-26 $2.84 $3.83 $4.82
2022-07-27 $2.90 $3.89 $4.88
2022-07-28 $2.96 $3.95 $4.94
2022-07-29 $3.02 $4.01 $5.00
2022-08-01 $3.08 $4.07 $5.06
2022-08-02 $3.14 $4.13 $5.12
2022-08-03 $3.20 $4.19 $5.18
2022-08-04 $3.26 $4.25 $5.24
2022-08-05 $3.32 $4.31 $5.30
2022-08-08 $3.38 $4.37 $5.36
2022-08-09 $3.44 $4.43 $5.43
2022-08-10 $3.50 $4.49 $5.49
2022-08-11 $3.56 $4.55 $5.55
2022-08-12 $3.62 $4.61 $5.61
2022-08-15 $3.68 $4.68 $5.67
2022-08-16 $3.74 $4.74 $5.73
2022-08-17 $3.80 $4.80 $5.79

IMPROVE YOUR TRADING GAME WITH A GOLDEN STAR

From 26 533 stocks, only a few dozen will trigger such a signal!

About Evoke Pharma

Evoke Pharma Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. The company develops EVK-001, a metoclopramide nasal spray, which is in Phase III clinical trials for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Evoke Pharma, Inc. was founded in 2007 and is headquartered in Solana Beach, California.... Read more

.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT